Researchers validated a novel wearable ultrasound blood pressure (BP) sensor, confirming its accuracy and safety across diverse clinical settings.
CAMP4, preparing for IPO, announces partnership with BioMarin
Regulatory RNA startup CAMP4 Therapeutics has inked another collaboration deal as it prepares for an initial public offering. The Cambridge, MA-based startup has lined up